Response to ‘D276G mutation is associated with a poor prognosis in imatinib mesylate-resistant chronic myeloid leukemia patients’ by Leguay et al.

Posted by rob on October 25, 2005 under Uncategorized | Be the First to Comment

No abstract yet

Piazza RG, Magistroni V, Franceschino A, Gambacorti-Passerini C

Leukemia. 2005 Oct 20;

Response to ‘D276G mutation is associated with a poor prognosis in imatinib mesylate-resistant chronic myeloid leukemia patients’ by Leguay et al.